BIRC5 and neoplasm: Combination of NVP-AEW541 and MK2206 produced the most prominent anti-tumor effects in both Hep3B and Huh7 models (Figure 5A), associated with a significant increase in tumor cell apoptosis and suppression of survivin expression than single-agent treatment.